Art. 2 Decision_act (EU) 1997/348

In forcesince 23 May 1997
1.

The Community shall make arrangements for formulation, production, bottling and distribution of vaccines against foot-and-mouth disease produced from antigens kept in existing antigen banks, initially up to a maximum cost of ECU 1,5 million.

2.

The action referred to in paragraph 1 shall be organized by the Commission.